Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.
- DOI
- 10.1093/rheumatology/keaf232
- Published
- 2025-09-01
- Container
- Rheumatology (Oxford)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keaf232,
title = {Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.},
author = {Delvino P and Quartuccio L and Robson JC and Ferretti VV and Klersy C and Alberici F and Bagnasco D and Berti A and Caminati M and Camoni M and Cid MC and Conticini E and Costanzo G and de Moreuil C and Del Giacco S and Espigol-Frigole G and Franceschini F and Iorio L and Kernder A and Lo Gullo A and Losappio L and Manna E and Maule M and Milanesi A and Montecucco C and Negrini S and Padoan R and Regola F and Ricciardi L and Schroeder J and Terrier B and Toniati P and Torracca F and Treppo E and Urban ML and Vaglio A and Emmi G and Monti S and European EGPA Study Group.},
year = {2025},
journal = {Rheumatology (Oxford)},
doi = {10.1093/rheumatology/keaf232},
url = {https://doi.org/10.1093/rheumatology/keaf232}
}RIS
TY - JOUR TI - Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study. AU - Delvino P AU - Quartuccio L AU - Robson JC AU - Ferretti VV AU - Klersy C AU - Alberici F AU - Bagnasco D AU - Berti A AU - Caminati M AU - Camoni M AU - Cid MC AU - Conticini E AU - Costanzo G AU - de Moreuil C AU - Del Giacco S AU - Espigol-Frigole G AU - Franceschini F AU - Iorio L AU - Kernder A AU - Lo Gullo A AU - Losappio L AU - Manna E AU - Maule M AU - Milanesi A AU - Montecucco C AU - Negrini S AU - Padoan R AU - Regola F AU - Ricciardi L AU - Schroeder J AU - Terrier B AU - Toniati P AU - Torracca F AU - Treppo E AU - Urban ML AU - Vaglio A AU - Emmi G AU - Monti S AU - European EGPA Study Group. PY - 2025 JO - Rheumatology (Oxford) DO - 10.1093/rheumatology/keaf232 UR - https://doi.org/10.1093/rheumatology/keaf232 ER -
APA
P, D., L, Q., JC, R., VV, F., C, K., F, A., D, B., A, B., M, C., M, C., MC, C., E, C., G, C., C, D. M., S, D. G., G, E., F, F., L, I., A, K., A, L. G., L, L., E, M., M, M., A, M., C, M., S, N., R, P., F, R., L, R., J, S., B, T., P, T., F, T., E, T., ML, U., A, V., G, E., S, M., & Group., E. E. S. (2025). Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaf232
Source records
- europe-pmc · retrieved 2026-11-10T14:53:45.245Z
- hal · retrieved 2026-11-10T14:53:45.311Z